SWM
ABEO icon

Spire Wealth Management’s Abeona Therapeutics ABEO Stock Holding History

Spire Wealth Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-740
Closed -$33K – 2562
2021
Q1 		$33K Buy
+740
New +$40.8K ﹤0.01% 1926

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Spire Wealth Management's ABEO Position: Q2 2021 in Review

Spire Wealth Management sold out of Abeona Therapeutics (ABEO) in Q2 2021, closing a stake of 740 shares — an estimated $33K sold.

Spire Wealth Management first reported a position in ABEO in Q1 2021 and held it in 1 quarter. The position peaked at $33K in Q1 2021. 70 funds tracked by Wall St. Rank hold ABEO as of Q2 2021.

  • Spire Wealth Management reported no remaining Abeona Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Spire Wealth Management sold 740 Abeona Therapeutics shares in Q2 2021, an estimated $33K.
  • Spire Wealth Management first reported a position in Abeona Therapeutics in Q1 2021 and held it in 1 quarter.
  • Spire Wealth Management's Abeona Therapeutics position peaked at $33K in Q1 2021.
  • 70 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2021.

Based on Spire Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.